Barretos Cancer Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Brazil (1962)

Organization Overview

First Clinical Trial
2007
NCT00540904
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Barretos Cancer Hospital | Hospital de Câncer de Barretos | Lucas Vieira dos Santos

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Squamous Cell (Phase 3)

Colorectal Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 2)

Hereditary Breast and Ovarian Cancer Syndrome (Phase 2)

Keratosis (Phase 3)

Keratosis, Actinic (Phase 3)

Kidney Diseases (Phase 2)

Neoplasms (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 17